NDC 58406-055

ENBREL

Etanercept

ENBREL is a Subcutaneous Solution in the Human Prescription Drug category. It is labeled and distributed by Immunex Corporation. The primary component is Etanercept.

• Product ID: 58406-055_206107f9-8738-4e17-af9f-ee8fa5f7cf26
• NDC: 58406-055
• Product Type: Human Prescription Drug
• Proprietary Name: ENBREL
• Generic Name: Etanercept
• Dosage Form: Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-03-05
• Marketing Category: BLA / BLA
• Application Number: BLA103795
• Labeler Name: Immunex Corporation
• Substance Name: ETANERCEPT
• Active Ingredient Strength: 25 mg/.5mL
• Pharm Classes: Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 58406-055-04

4 VIAL, SINGLE-DOSE in 1 CARTON (58406-055-04) > .5 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2020-03-05
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ENBREL" or generic name "Etanercept"

NDC	Brand Name	Generic Name
50090-3531	ENBREL	etanercept
50090-4490	ENBREL	etanercept
50090-4590	ENBREL	etanercept
58406-010	ENBREL	etanercept
58406-021	ENBREL	etanercept
58406-032	ENBREL	etanercept
58406-044	ENBREL	etanercept
58406-455	ENBREL	ENBREL
58406-456	ENBREL	ENBREL
58406-425	ENBREL	ENBREL
58406-435	ENBREL	ENBREL
58406-445	ENBREL	ENBREL
58406-446	ENBREL	ENBREL
58406-055	ENBREL	ENBREL